The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

Published:2012 Issue:1 Volume:12 Page:21
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell International

Author:

Jelly Neil D,Hussain Issam I,Eremin Jennifer,Eremin Oleg,El-Sheemy Mohamed

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Reference20 articles.

1. Risk factors and epidemiology of breast cancer

2. Multidrug Resistance in Locally Advanced Breast Cancer

3. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

4. Mechanisms of Cancer Drug Resistance

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response;BMC Complementary and Alternative Medicine;2017-04-11

2. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells;Oncotarget;2016-10-12

3. Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression;Journal of Photochemistry and Photobiology B: Biology;2014-12

4. The multiple facets of drug resistance: one history, different approaches;Journal of Experimental & Clinical Cancer Research;2014-04-28

5. Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: Effects associated with STAT3/Survivin;Cancer Letters;2013-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3